Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Sjælland Forside
Hjælp og OSS
Link åbnes på en ny fane
Dansk
English
Søg efter indhold i Region Sjælland
Forside
Profiler
Forskningsenheder
Projekter
Publikationer
Priser
Aktiviteter
Undervisning og vejledning
Presse/medier
Impacts
High on-treatment platelet reactivity in Danish hyper-acute ischaemic stroke patients
Charlotte L. Rath
*
, Niklas Rye Jørgensen
,
Troels Wienecke
*
Corresponding author af dette arbejde
Neurologisk Afdeling
Publikation
:
Bidrag til tidsskrift
›
Artikel
›
Forskning
›
peer review
Oversigt
Fingeraftryk
Fingeraftryk
Udforsk hvilke forskningsemner 'High on-treatment platelet reactivity in Danish hyper-acute ischaemic stroke patients' indeholder.
Sorter
Vægt
Alfabetisk
Keyphrases
Stroke Patients
100%
High On-treatment Platelet Reactivity
100%
Hyperacute Stroke
100%
Clopidogrel
66%
Transient Ischemic Attack
50%
Stroke Ischemic
50%
Ischemic Stroke
33%
Blood Collection
33%
Stroke Phases
33%
Antiplatelet Drugs
33%
VerifyNow P2Y12
33%
Blood Samples
16%
Comorbidity
16%
Platelets
16%
Randomized Trial
16%
Acute Ischemic Stroke
16%
Co-medication
16%
Antiplatelet Therapy
16%
Bolus
16%
Antiplatelet Agents
16%
Blood Analysis
16%
Early Recurrent Stroke
16%
Unit Values
16%
Ictus
16%
Hyperacute
16%
Concomitant Therapy
16%
Clinical Outcome Assessment
16%
Recurrent Ischemic Stroke
16%
Recurrent Stroke Risk
16%
Vascular Events
16%
Blood Sampling
16%
Symptom Onset
16%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Ischemia
100%
Clopidogrel
80%
Cerebrovascular Accident
80%
Antiplatelet
60%
Transient Ischemic Attack
60%
Prevalence
20%
Antithrombocytic Agent
20%
Comorbidity
20%
Nursing and Health Professions
Brain Ischemia
100%
Platelet
100%
Cerebrovascular Accident
44%
Clopidogrel
44%
Transient Ischemic Attack
33%
Blood Sampling
33%
Outcome Assessment
11%
Clinical Outcome
11%
Prevalence
11%
Antithrombocytic Agent
11%
Comorbidity
11%
Neuroscience
Brain Ischemia
100%
Platelet
100%
Clopidogrel
44%
Cerebrovascular Accident
44%
Transient Ischemic Attack
33%
P2Y12
22%
Antiplatelet Drug
11%
Comorbidity
11%